The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study
Abstract
BACKGROUND: Investigation of a possible effect of metformin on androgen levels in pregnant women with polycystic ovary syndrome (PCOS). METHODS: A prospective, randomized, double-blind, placebo-controlled pilot study was conducted. Forty pregnant women with PCOS received diet and lifestyle counselling and were randomized to either metformin 850 mg twice daily or placebo. Primary outcome measures were changes in serum levels of dehydroepiandrosterone sulphate, androstenedione, testosterone, sex hormone-binding globulin, and free testosterone index. Secondary outcome measures were pregnancy complications and outcome. Two-tailed t-tests and chi2-tests were used. RESULTS: Maternal androgen levels were unaffected by metformin treatment in pregnant women with PCOS. While none of the 18 women in the metformin group experienced a severe pregnancy or post-partum complication, seven of the 22 (32%) women experienced severe complications in the placebo group (P = 0.01). CONCLUSIONS: Metformin treatment did not reduce maternal androgen levels in pregnant women with PCOS. In the metformin-treated group we observed a reduction of severe, pregnancy and post-partum complications. Metformin treatment of pregnant PCOS women may reduce complications during pregnancy and in the post-partum period.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Metzger, B. E., Buchanan, T. A., Coustan, D. R., de Leiva, A., Dunger, D. B., Hadden, D. R., Hod, M., Kitzmiller, J. L., Kjos, S. L., Oats, J. N., et al. (2007) · Diabetes Care · doi:10.2337/dc07-s225 · Cited by 1,908
Velazquez, E. M., Mendoza, S., Hamer, T., Sosa, F., & Glueck, C. J. (1994) · Metabolism · doi:10.1016/0026-0495(94)90209-7 · Cited by 865
Pasquali, R., Gambineri, A., Biscotti, D., Vicennati, V., Gagliardi, L., Colitta, D., Fiorini, S., Cognigni, G. E., Filicori, M., & Morselli-Labate, A. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6738 · Cited by 635 · cited 1×
“The use of the anti-diabetic drug metformin in the treatment of non-pregnant PCOS women is quite well established (Wortsman et al., 1991; Velazquez et al., 1994, 1997; Nestler and Jakubowicz, 1997; Morin-Papunen et al., 1998; Moghetti et al., 2000; Pasquali et al., 2000; Fleming et al., 2002).”
BackgroundObstetric outcome in women with polycystic ovarian syndrome
Mikola, M. (2001) · Human Reproduction · doi:10.1093/humrep/16.2.226 · Cited by 206 · cited 2×
“Gestational diabetes mellitus (GDM), pre-eclampsia (PE), and premature delivery has been associated with PCOS (Diamant et al., 1982; Gjonnaess, 1989; de Vries et al., 1998; Radon et al., 1999; Mikola et al., 2001; Bjercke et al., 2002).”
BackgroundResult
Cited by
Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976
Metformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291
Consensus on infertility treatment related to polycystic ovary syndrome
(2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.09.041 · Cited by 730
Palomba, S., Falbo, A., Zullo, F., & Orio, F. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0030 · Cited by 426
Metformin versus placebo in obese pregnant women without diabetes mellitus
Syngelaki, A., Nicolaides, K. H., Balani, J., Hyer, S., Akolekar, R., Kotecha, R., Pastides, A., & Shehata, H. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1509819 · Cited by 394
Naderpoor, N., Shorakae, S., de Courten, B., Misso, M. L., Moran, L. J., & Teede, H. J. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv025 · Cited by 334
Roos, N., Kieler, H., Sahlin, L., Ekman-Ordeberg, G., Falconer, H., & Stephansson, O. (2011) · BMJ · doi:10.1136/bmj.d6309 · Cited by 316
Vanky, E., Stridsklev, S., Heimstad, R., Romundstad, P., Skogøy, K., Kleggetveit, O., Hjelle, S., von Brandis, P., Eikeland, T., Flo, K., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0853 · Cited by 315
“It is noteworthy that metformin, an insulin-sensitizing drug, did not reduce the prevalence of GDM.”
BackgroundMethodResultSelf-citationNaderpoor, N., Shorakae, S., de Courten, B., Misso, M. L., Moran, L. J., & Teede, H. J. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmv063 · Cited by 255
Romero, R., Erez, O., Hüttemann, M., Maymon, E., Panaitescu, B., Conde-Agudelo, A., Pacora, P., Yoon, B. H., & Grossman, L. I. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.06.003 · Cited by 253
Placental passage of metformin in women with polycystic ovary syndrome
Vanky, E., Zahlsen, K., Spigset, O., & Carlsen, S. M. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.051 · Cited by 245
Self-citationHanem, L. G. E., Stridsklev, S., Júlíusson, P. B., Salvesen, Ø., Roelants, M., Carlsen, S. M., Ødegård, R., & Vanky, E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02419 · Cited by 199
Self-citationLøvvik, T. S., Carlsen, S. M., Salvesen, Ø., Steffensen, B., Bixo, M., Gómez-Real, F., Lønnebotn, M., Hestvold, K. V., Zabielska, R., Hirschberg, A. L., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30002-6 · Cited by 176
Self-citationButalia, S., Gutierrez, L., Lodha, A., Aitken, E., Zakariasen, A., & Donovan, L. (2017) · Diabetic Medicine · doi:10.1111/dme.13150 · Cited by 170
Barrett, E. S., Hoeger, K. M., Sathyanarayana, S., Abbott, D. H., Redmon, J. B., Nguyen, R. H. N., & Swan, S. H. (2018) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174417001118 · Cited by 145
Cassina, M., Donà, M., Di Gianantonio, E., Litta, P., & Clementi, M. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu022 · Cited by 143
“…an inappropriate control group (women exposed to metformin at the time of conception and until confirmation of pregnancy) (Batukan and Baysal, 2001; Vanky et al., 2004, 2010; Qublan and Malkawi, 2005; Thatcher and Jackson, 2006; Turner et al., 2006; Begum et al., 2009; Qublan et al., 2009;…”
BackgroundDomecq, J. P., Prutsky, G., Mullan, R. J., Sundaresh, V., Wang, A. T., Erwin, P. J., Welt, C., Ehrmann, D., Montori, V. M., & Murad, M. H. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2374 · Cited by 115
Lautatzis, M.-E., Goulis, D. G., & Vrontakis, M. (2013) · Metabolism · doi:10.1016/j.metabol.2013.06.006 · Cited by 113
Growth, body composition and metabolic profile of 8-year-old children exposed to metformin in utero
Rø, T. B., Ludvigsen, H. V., Carlsen, S. M., & Vanky, E. (2012) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2012.712319 · Cited by 85
Self-citationLi, X.-J., Yu, Y.-X., Liu, C.-Q., Zhang, W., Zhang, H.-J., Yan, B., Wang, L.-Y., Yang, S.-Y., & Zhang, S.-H. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03917.x · Cited by 67
Glueck, C. J., Salehi, M., Sieve, L., & Wang, P. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.01.011 · Cited by 58
Palomba, S., Orio, F., Falbo, A., Russo, T., Tolino, A., & Zullo, F. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.04.021 · Cited by 56
Zhuo, Z., Wang, A., & Yu, H. (2014) · Journal of Diabetes Research · doi:10.1155/2014/381231 · Cited by 55
Tan, X., Li, S., Chang, Y., Fang, C., Liu, H., Zhang, X., & Wang, Y. (2016) · Clinical and Investigative Medicine · doi:10.25011/cim.v39i4.27091 · Cited by 51
Use of metformin in the treatment of polycystic ovary syndrome
Genazzani, A. D., Ricchieri, F., & Lanzoni, C. (2010) · Women's Health · doi:10.2217/whe.10.43 · Cited by 51
Feng, L., Lin, X.-F., Wan, Z.-H., Hu, D., & Du, Y.-K. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1041906 · Cited by 50
“Though not all the controls got conception with metformin, two studies [24,25] were included after group discussion because of the strict design and implementation, limited randomized controlled trials and inter-class equilibration between study and control group.”
BackgroundResultInfluentialSalvesen, K. Å., Vanky, E., & Carlsen, S. M. (2007) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.3965 · Cited by 48
“Gestational age at inclusion (days) 55 (17) 59 (14) 0.”
BackgroundSelf-citationFornes, R., Simin, J., Nguyen, M. H., Cruz, G., Crisosto, N., van der Schaaf, M., Engstrand, L., & Brusselaers, N. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-022-00905-6 · Cited by 44
Bolton, S., Cleary, B., Walsh, J., Dempsey, E., & Turner, M. J. (2009) · European Journal of Pediatrics · doi:10.1007/s00431-008-0737-7 · Cited by 45
Bidhendi Yarandi, R., Behboudi-Gandevani, S., Amiri, M., & Ramezani Tehrani, F. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0453-7 · Cited by 29
Doi, S. A. R., Furuya‐Kanamori, L., Toft, E., Musa, O. A. H., Islam, N., Clark, J., & Thalib, L. (2020) · Obesity Reviews · doi:10.1111/obr.12964 · Cited by 39
Metformin before and during pregnancy and lactation in polycystic ovary syndrome
Glueck, C. J., & Wang, P. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.2.191 · Cited by 36
Abdalla, M. A., Shah, N., Deshmukh, H., Sahebkar, A., Östlundh, L., Al-Rifai, R. H., Atkin, S. L., & Sathyapalan, T. (2022) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188221127142 · Cited by 33
Zhao, J., Liu, X., & Zhang, W. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0603-3394 · Cited by 31
Kjøtrød, S. B., Sunde, A., von Düring, V., & Carlsen, S. M. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.11.069 · Cited by 22
Fougner, S. L., Vanky, E., Løvvik, T. S., & Carlsen, S. M. (2021) · PLOS ONE · doi:10.1371/journal.pone.0254895 · Cited by 23
Self-citation
Metadata
- Authors
- Vanky, E.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-06-03
- Volume
- 19
- Issue
- 8
- Pages
- 1734-1740
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2169777843
- Cited by
- 237
- References
- 6
- FWCI
- 15.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.